Xvivo Perfusion Past Earnings Performance
Past criteria checks 4/6
Xvivo Perfusion has been growing earnings at an average annual rate of 68.4%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 30.8% per year. Xvivo Perfusion's return on equity is 9.8%, and it has net margins of 27.2%.
Key information
68.4%
Earnings growth rate
66.8%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 30.8% |
| Return on equity | 9.8% |
| Net Margin | 27.2% |
| Next Earnings Update | 28 Jan 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Xvivo Perfusion makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 751 | 204 | 358 | 144 |
| 30 Jun 24 | 699 | 121 | 342 | 140 |
| 31 Mar 24 | 643 | 100 | 328 | 140 |
| 31 Dec 23 | 598 | 92 | 309 | 136 |
| 30 Sep 23 | 573 | 24 | 296 | 109 |
| 30 Jun 23 | 524 | 27 | 274 | 98 |
| 31 Mar 23 | 463 | 28 | 247 | 79 |
| 31 Dec 22 | 415 | 18 | 223 | 69 |
| 30 Sep 22 | 370 | 30 | 211 | 61 |
| 30 Jun 22 | 328 | 23 | 186 | 55 |
| 31 Mar 22 | 293 | 7 | 171 | 58 |
| 31 Dec 21 | 258 | 8 | 153 | 54 |
| 30 Sep 21 | 233 | -24 | 135 | 65 |
| 30 Jun 21 | 221 | -37 | 137 | 66 |
| 31 Mar 21 | 192 | -44 | 116 | 63 |
| 31 Dec 20 | 180 | -44 | 108 | 67 |
| 30 Sep 20 | 182 | -26 | 95 | 58 |
| 30 Jun 20 | 194 | -6 | 79 | 64 |
| 31 Mar 20 | 220 | 12 | 87 | 65 |
| 31 Dec 19 | 221 | 5 | 93 | 63 |
| 30 Sep 19 | 217 | 12 | 86 | 57 |
| 30 Jun 19 | 203 | 7 | 86 | 52 |
| 31 Mar 19 | 193 | 9 | 79 | 51 |
| 31 Dec 18 | 188 | 13 | 70 | 48 |
| 30 Sep 18 | 171 | 13 | 68 | 45 |
| 30 Jun 18 | 162 | 13 | 67 | 43 |
| 31 Mar 18 | 153 | 10 | 62 | 41 |
| 31 Dec 17 | 148 | 6 | 64 | 39 |
| 30 Sep 17 | 145 | 0 | 60 | 40 |
| 30 Jun 17 | 145 | 0 | 63 | 41 |
| 31 Mar 17 | 142 | 0 | 61 | 39 |
| 31 Dec 16 | 138 | 2 | 56 | 37 |
| 30 Sep 16 | 132 | 5 | 56 | 34 |
| 30 Jun 16 | 127 | 7 | 46 | 32 |
| 31 Mar 16 | 122 | 6 | 46 | 32 |
| 31 Dec 15 | 120 | 5 | 45 | 31 |
| 30 Sep 15 | 113 | 4 | 42 | 33 |
| 30 Jun 15 | 109 | 4 | 40 | 31 |
| 31 Mar 15 | 98 | 3 | 37 | 26 |
| 31 Dec 14 | 85 | 5 | 34 | 23 |
| 30 Sep 14 | 79 | 6 | 33 | 18 |
| 30 Jun 14 | 74 | 7 | 32 | 17 |
| 31 Mar 14 | 71 | 7 | 30 | 16 |
| 31 Dec 13 | 69 | 8 | 29 | 15 |
Quality Earnings: 3XV has a high level of non-cash earnings.
Growing Profit Margin: 3XV's current net profit margins (27.2%) are higher than last year (4.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3XV's earnings have grown significantly by 68.4% per year over the past 5 years.
Accelerating Growth: 3XV's earnings growth over the past year (748.3%) exceeds its 5-year average (68.4% per year).
Earnings vs Industry: 3XV earnings growth over the past year (748.3%) exceeded the Medical Equipment industry 10.1%.
Return on Equity
High ROE: 3XV's Return on Equity (9.8%) is considered low.